Insulin aspart was approved for medical use in the United States in 2000. In 2020, it was the 80th most commonly prescribed medication in the United States, with more than 9million prescriptions. Manufacturing involves yeast, which have had the gene for insulin aspart put into their genome. This yeast then makes the insulin, which is harvested from the bioreactor.
